Spots Global Cancer Trial Database for A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas

Name: Bertram Glass, Prof. Dr.

Affiliation: German Society of Cancer e.V.

Role: STUDY_DIRECTOR

Name: Martin Gramatzki, MD PhD

Affiliation: Städtisches Krankenhaus Kiel, II. Med. Uniklinik, Kiel, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Mattias Witzens Harig, MD PhD

Affiliation: Abteilung Innere Medizin V, Hämatologie, Onkologie, Heidelberg, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Bernd Hertenstein, MD PhD

Affiliation: Klinikum Bremen-Mitte gGmbH, Medizinische Klinik I, Bremen, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Georg Heß, MD PhD

Affiliation: III Med., Schwerpunkt Hämatologie / Onkologie, Mainz, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Dorothea Kofahl-Krause, MD PhD

Affiliation: MHH, Hämatologie, Hämostaseologie und Onkologie, Hannover, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Norbert Schmitz, MD PhD

Affiliation: Asklepios Klinik St. Georg, Hämatologische Abt., Hamburg, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Jörg Schubert, MD PhD

Affiliation: Universitätskliniken d. Saarlandes, Med. I, Homburg/Saar, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Lutz Uharek Uharek, MD PhD

Affiliation: Charité - Campus Benjamin Franklin, Med. III, Berlin, Germany

Role: PRINCIPAL_INVESTIGATOR